Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program
NCT04350788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124
Last updated 2020-09-23
Summary
The purpose of this research study is to examine the feasibility of the enhanced survivorship care plans (ESCPs, regular SCPs with the a web-based couple-focused symptom self-management project (PERC) or National Cancer Institute prostate cancer web links) and to conduct an initial benefit assessment of enhanced survivorship care plans among prostate cancer patients transitioning from active treatment to post-treatment self-management, and their partners.
Participation of this study lasts for about for 16 weeks. Depending on participants' need for information, it takes 10-30 minutes of their time each week to review the information about prostate cancer.
Eligible and consented patients with newly treated localized prostate cancer and your partner (couples) are randomly assigned to the regular survivorship care plan (SCPs) with the NCI website or the enhanced survivorship care plans (SCP plus the web-based prostate cancer education program, PERC) groups. They complete baseline (T1, prior to randomization) and 4-month post-T1 follow-up measures (T2).
Conditions
Interventions
- OTHER
-
Survivorship Care Plan
Participants visit the NCI prostate cancer website in addition to their standardized post-treatment survivorship care
- OTHER
-
Enhanced Survivorship Care Plan
In addition to their standardized post-treatment survivorship care, participants visit the prostate cancer education resources for couples (PERC) website that was based on scientific evidence and input from stakeholders including PC patients, partners, and cancer care providers. Participants learn about skills and knowledge about how to enhance their positive appraisals of symptoms and self-efficacy in symptom management through information and skills training, fostering healthy behaviors, and facilitating social support
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
UNC Lineberger Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Lixin Song, RN, PhD · University of North Carolina, Chapel Hill
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-03
- Primary Completion
- 2018-11-30
- Completion
- 2019-04-15
Countries
- United States
Study Locations
More Related Trials
-
Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing
NCT03511235 ·Status: COMPLETED
-
Study of Treatment Choice in Patients With Localized Prostate Cancer
NCT01177865 ·Status: UNKNOWN ·Phase: NA
-
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy
NCT00148772 ·Status: COMPLETED ·Phase: PHASE2
-
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
NCT04189770 ·Status: ACTIVE_NOT_RECRUITING
-
Towards Optimal Prescription of Chemotherapy in Prostate Cancer
NCT02512185 ·Status: COMPLETED
-
Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer
NCT00272038 ·Status: COMPLETED ·Phase: PHASE2
-
Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks
NCT01844999 ·Status: COMPLETED ·Phase: NA
-
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting
NCT03912883 ·Status: ACTIVE_NOT_RECRUITING
-
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners
NCT03575832 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Surgery in Treating Patients With Prostate Cancer
NCT00002938 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
NCT00455624 ·Status: COMPLETED
-
Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
NCT00082732 ·Status: COMPLETED ·Phase: PHASE1
-
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
NCT00116142 ·Status: COMPLETED ·Phase: PHASE3
-
EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression
NCT04266431 ·Status: COMPLETED ·Phase: NA
-
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
NCT02008058 ·Status: COMPLETED
-
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
NCT02380274 ·Status: COMPLETED
-
To Live Better After Prostate Cancer Treatment:
NCT05100121 ·Status: RECRUITING ·Phase: NA
-
Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment
NCT04890314 ·Status: COMPLETED
-
The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer
NCT00487721 ·Status: COMPLETED ·Phase: PHASE2
-
Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8
NCT02470936 ·Status: COMPLETED ·Phase: NA
-
Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment
NCT01018901 ·Status: COMPLETED ·Phase: NA
-
Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)
NCT00452387 ·Status: TERMINATED ·Phase: PHASE2
-
Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial
NCT03658486 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer
NCT00582842 ·Status: COMPLETED
-
Prostate Cancer - Patient Empowerment Program
NCT03660085 ·Status: COMPLETED ·Phase: NA